Visceral leishmaniasis in HIV-infected patients.
Flegg
P J
PJ
Brettle
R P
RP
D000981:Antiprotozoal Agents / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000382:microbiology / Q000469:parasitology; D002487:Centers for Disease Control and Prevention, U.S.; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000145:classification / Q000150:complications*; D007958:Leukocyte Count; D014481:United States
D000981:Antiprotozoal Agents